HMGB1 and neoplasm: Nevertheless, since this immunosuppressive effect of HMGB1 is observed in established tumors where the tumor environment is likely to contain high levels of ROS [53], it could be that the inactive oxidized form of HMGB1 is responsible for the observed tolerogenic effects in this scenario.